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Text: Background 
IV antibiotics are needed for rescue when preventative therapy fails to achieve stability. Understanding the 
distribution of IV days among people with CF can provide insight into the care they need. 
 
Aim 
To determine baseline characteristics that are associated with higher IV use among adults with CF 
 
Methods 
The 2012 & 2013 data on age, sex, BMI, FEV1, pancreatic status, Pseudomonas status & CF related diabetes 
IRUWKRVHDJHG\HDUVZHUHREWDLQHGIURPWKH8.&)UHJLVWU\,9GD\VGDWDIRU-2013 were also 
obtained. Those on ivacaftor were excluded. Multiple regression was performed using current year IV days as 
the dependent variable and demographic variables & prior year IV days as the covariates for both 2012 & 
2013. Based on these results, tree-based method (Zhang & Bracken, AJE 1996) was used to divide the study 
sample into clinically meaningful subgroups. 
 
Results 
For both years, prior year IV use was the strongest predictor for current year IV use, followed by FEV1. 
People with prior year IV use >14 days has a 4-6 fold increase in IV use for the subsequent year. 
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One way 
ANOVA 
(comparing 
across the 4 
groups) p-value 
2012: number of 
adults with CF 1617 485 1150 1480   
2012: IV days, 
mean (SD) 5.5 (11.2) 27.7 (28.1) 12.3 (19.9) 55.8 (50.2) < 0.001 
2012: IV days, 
median (IQR) 0 (0-10) 22 (11-41) 0 (0-15) 43 (24-74)   
2013: number of 
adults with CF 1678 440 1148 1437   
2013: IV days, 
mean (SD) 4.7 (9.9) 26.6 (24.5) 12.8 (20.4) 53.8 (46.0) < 0.001 
2013: IV days, 
median (IQR) 0 (0-0) 24 (7-41) 0 (0-14) 42 (24-71)   
[IV use by group] 
 
 
Conclusion 
People with prior high levels of rescue will often continue to need high levels of rescue even if they have good 
lung function. The reasons for this require further investigations. 
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